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AbstrACt
Objectives The objective was to the undertake nominal 
group technique (NGT) to evaluate current exercise 
adherence measures and isolated domains to develop 
stakeholder consensus on the domains to include in 
the measurement of therapeutic exercise adherence for 
patients with musculoskeletal disorders.
Design A 1- day NGT workshop was convened. Six 
exercise adherence measures were presented to the 
group that were identified in our recent systematic review. 
Discussions considered these measures and isolated 
domains of exercise adherence. Following discussions, 
consensus voting identified stakeholder agreement on the 
suitability of the six offered adherence measures and the 
inclusion of isolated domains of exercise adherence in 
future measurement.
setting One stakeholder NGT workshop held in Sheffield, 
UK.
Participants Key stakeholders from the UK were 
invited to participate from four identified populations. 14 
participants represented patients, clinicians, researchers 
and service managers.
results All six exercise adherence measures were 
deemed not appropriate for use in clinical research or 
routine practice with no measure reaching 70% group 
agreement for suitability, relevance, acceptability or 
appropriateness. Three measures were deemed feasible 
to use in clinical practice. 25 constructs of exercise 
adherence did reach consensus threshold and were 
supported to be included as domains in the future 
measurement of exercise adherence.
Conclusion A mixed UK- based stakeholder group 
felt these six measures of exercise adherence were 
unacceptable. Differences in opinion within the 
stakeholder group highlighted the lack of consensus as to 
what should be measured, the type of assessment that is 
required and whose perspective should be sought when 
assessing exercise adherence. Previously unused domains 
may be needed alongside current ones, from both a 
clinician's and patient’s perspective, to gain understanding 
and to inform future measurement development. Further 
conceptualisation of exercise adherence is required from 
similar mixed stakeholder groups in various socioeconomic 
and cultural populations.
IntrODuCtIOn
Within the UK population, the prevalence 
of musculoskeletal disorders (MSDs) is esti-
mated to be 38%.1 Prevalence increases mark-
edly with age1 and is likely to continue to rise 
due to the ageing population and increas-
ingly sedentary lifestyles.2 3 MSDs cause more 
functional limitations than any other group 
of disorders within the adult population and 
lead to vast healthcare expenditure and loss 
of work.4 Therapeutic exercise is commonly 
strengths and limitations of this study
 ► This is first UK- based patient- centred nominal group 
technique (NGT) workshop to investigate measures 
of therapeutic exercise adherence for patients with 
musculoskeletal disorders.
 ► The domains included for stakeholder consensus 
were derived from a recent robust systematic review 
of adherence measures.
 ► Participants were included in preworkshop dia-
logue to recognise their understanding of the topic 
area and to design the workshop to account for the 
discrepancy in mixed stakeholder knowledge and 
perceptions.
 ► The number of NGT workshop participants is a pos-
sible limitation, although agreement about what 
constitutes an optimum group size could not be 
found.
 ► Findings will need to be substantiated with similar 
mixed stakeholder groups in various socioeconomic 
and cultural populations alongside others’ work to 
further conceptualise exercise adherence.
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recommended for the management of MSDs and may 
include strength and conditioning, aerobic exercise and 
functional activities.5 Adherence to therapeutic treat-
ment, defined as ‘the extent to which a person’s behaviour 
corresponds with agreed recommendations from a health-
care provider’,6 has been shown to enhance the effective-
ness of exercise programmes6 7 and to impede recurrent, 
persistent or disabling conditions.8 9 Conversely, non- 
adherence may be a missed opportunity for therapeutic 
benefit and may negatively affect treatment duration, 
the therapeutic relationship, waiting times, cost of care 
and may be responsible for non- significant research 
outcomes.10–13
Systematic reviews consistently show the beneficial 
effects of different types of exercise on key clinical 
outcomes, such as pain, physical function and quality of 
life,14–16 leading to clinical guidelines that advocate the 
use of exercise programmes to manage MSDs.17 18 Despite 
its importance, adherence to clinic- based exercise proto-
cols is approximately 50%19 20 and is often lower for unsu-
pervised home exercise programmes.21 22 Interventions 
exist that may potentially improve exercise adherence 
for MSDs.5 23–25 Although supportive evidence exists for 
the use of therapeutic exercise across many MSD condi-
tions, no gold standard measure of exercise adherence 
currently exists,26–28 with many measures being unre-
producible or exhibiting limited evidence of essential 
measurement and practical properties.29–31
Our own recent systematic review30 identified 238 
different measures of exercise adherence in musculoskel-
etal settings. Of these, only six measures (Sports Injury 
Rehabilitation Adherence Scale (SIRAS), Rehabilitation 
Adherence Questionnaire (modified), Adherence to 
Exercise Scale for Older Patients, Hopkins Rehabilitation 
Engagement Rating Scale (HRERS), Community Healthy 
Activities Model Programme for Seniors and Pittsburgh 
Rehabilitation Participation Scale (PRPS)) had been eval-
uated, by 11 studies, for the specific purpose of measuring 
exercise adherence. The review concluded that there 
was inadequate evidence of theoretical, measurement or 
practical properties for any of the measures. The absence 
of evidence does not preclude the use of these measures, 
and further evaluation may still indicate that they are suit-
able measures of exercise adherence. Consequently, the 
primary aim of this study was to use the NGT with a mixed 
stakeholder group to discuss and rank the six measures 
of exercise adherence to reach consensus on their suit-
ability for use in a variety of settings. A secondary aim was 
to reach a similar consensus by discussing and ranking 
which domains of exercise adherence should be included 
in future measures.
MethODs
A 1- day workshop brought together key stakeholders to 
discuss how adherence to therapeutic exercise for MSD 
should be assessed, specifically, the suitability of six exer-
cise measures for use in research and clinical practice 
settings (study protocol available32). Therapeutic exercise 
was defined as ‘the systematic performance or execution 
of planned physical movements, postures, or activities 
intended to enable the patients to remediate or prevent 
impairments, enhance function, reduce risk, optimise 
overall health, and enhance fitness and well- being’.33
Nominal group technique (NGT) has been used to 
derive consensus by collating and ranking stakeholder 
views through its structured anonymous approach within 
face- to- face group meetings.34 35 The flexible method-
ology provides predetermined stages to develop partici-
pants’ responses, therefore quickly representing a mixed 
group on complex issues by prioritising their perspec-
tives.36 A modified NGT was employed to reach stake-
holder consensus regarding two questions:
1. How suitable are the six candidate measures of exer-
cise adherence with respect to
 ► Relevance (to their individual perspective)?
 ► Feasibility (for use in research and/or clinical prac-
tice settings)?
 ► Acceptability (to patients who are required to adhere 
to exercise regimes)?
 ► Appropriateness (to the musculoskeletal population)?
2. Which domains should be included in future measures 
of exercise adherence?
Using existing professional networks, the study 
targeted four key stakeholder groups (patients, clinicians, 
researchers and service managers) within the UK. A formal 
electronic invitation to participate in the NGT workshop 
was sent to potential participants with in all groups. The 
email included an information sheet detailing the study 
goals and research questions and offered the opportunity 
to ask questions about the study. Those who were willing 
and able to attend the workshop signed and returned a 
consent form. Prior to attending, participants received a 
further information pack summarising the results of our 
previous systematic review, a questionnaire, a copy of the 
six candidate measures and a list of the exercise adher-
ence domains contained within these measures. The 
domains were extracted from the candidate measures by 
one author (RM) and peer reviewed by a second (SM). 
The questionnaire asked participants to rate each of the 
six candidate measures of exercise adherence for use in 
research/clinical practice and the relative importance of 
including each domain of exercise adherence contained. 
Respondents were also asked to add comments and to 
rate any additional domains that they felt were important 
but missing. Completed questionnaires were returned in 
advance of the workshop to inform the structure of the 
discussions (results not reported).
The 5- hour workshop was held in one room within a 
university environment in Sheffield, UK. First, an overview 
of the systematic review and a summary of the findings 
of the postal questionnaires were provided. Participants 
were assigned to two discussion groups: lay representa-
tives (n=6) and all other participants (n=8). Members of 
the research team (SM, RM, MAH and KH) facilitated 
the group discussions. Two rounds of discussion focused 
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first on the candidate six measures then second on the 
isolated domains of exercise adherence. Throughout 
this second round, an iterative process was employed 
during discussions to reword suggested domains until 
agreement from the wider group was reached that the 
domain warranted consensus voting. Each round was 
concluded by a group spokesperson summarising their 
dialogue to all stakeholders, then finally a plenary semi-
structured session was held before undertaking the final 
consensus voting.
Each round of voting asked one question that required 
a dichotomous yes/no response for the measure or 
domain being considered. All questions were manda-
tory. The voting was conducted anonymously and digi-
tally on hand- held tablet devices using Google Forms 
to request and record responses in real time. Following 
the first round of discussion regarding the candidate 
six measures participants were asked, ‘Are the following 
measures (1) relevant, (2) feasible, (3) acceptable, (4) 
appropriate or (5) overall suitable when assessing adher-
ence to therapeutic exercise programmes?’ Following 
the second round of domain discussion, the question 
posed was ‘Should the following adherence domain be 
included in future measures of exercise adherence?’ For 
all, voting a response was required for using the measure 
or domain in clinical trials and routine clinical practice. 
A final summary session was convened and the results of 
voting were fed- back to participants. The Standards for 
Reporting Qualitative Research checklist was used when 
writing this report.37
Patient and public involvement
This research was developed and conducted in line with 
the INVOLVE framework.38 The proposed aims, design 
and methods of this research proposal were informed by 
discussion with the Barnsley Consumer Research Advi-
sory Group (CRAG) and the Allied Health Professionals 
special interest groups of the South Yorkshire Collabora-
tive Local Research Network. Both groups agreed that the 
project would be valuable considering the scale of non- 
adherence to exercise for MSDs within physiotherapy 
practice. Several recommendations from the Barnsley 
CRAG group shaped the development and conduct 
of the project to facilitate the involvement of patient 
participants.
Data analysis
Voting responses were captured by Google Forms and 
automatically populated into electronic spreadsheets. 
Data were analysed separately for each required response 
using Microsoft Excel V.16. The data were ranked in 
percentage agreement of ‘yes’ responses for all partici-
pants for each required response regarding the measure 
or domain. Consensus was defined as 70% participant 
agreement level in keeping with criterion for consensus 
recommendations.39 40
results
Fourteen participants consented to participate in the 
workshop, including lay representatives with experi-
ence of receiving exercise for an MSDr (n=6), clinicians 
who use therapeutic exercise for treating MSDs (n=3), 
researchers with expertise of exercise adherence or 
measurement (n=2) and service managers with account-
ability for musculoskeletal outpatient departments (n=3). 
All participants completed and returned the postal 
questionnaire, attended the consensus workshop and 
completed electronic consensus voting.
nGt: candidate exercise adherence measures
Three measures were deemed feasible to use with 
a consensus of greater than 70% being reached for 
completion of the SIRAS, HRERS and PRPS in routine 
clinical practice but not clinical trials. No other measure 
reached the consensus threshold for any other prop-
erty of suitability (table 1). The results demonstrate that 
stakeholders almost unanimously agree that all measures 
lack the essential qualities of relevance, acceptability and 
appropriateness for application in all settings, and conse-
quently, no measure is suitable for use in routine practice 
or clinical trials.
nGt: domains of exercise adherence
Nineteen exercise adherence domains were recognised 
and extracted from the six candidate measures and 
presented to the group alongside a further six proposed 
domains from the questionnaire. Following group discus-
sion and domain development, four additional domains 
of exercise adherence that had not previously been used 
in existing measures were included alongside the existing 
19 for consensus voting. Interpretation of the 23 domains 
highlighted two distinct categories of adherence domain: 
those which quantify the amount of exercise adherence 
and those which explored factors that influence exer-
cise adherence and allowed some understanding of 
the patient experience. The second consensus vote was 
conducted using the distinguishing terms ‘quantifying’ 
and ‘influencing’ domains as judged by the research team 
for clarity.
Twelve of the 16 quantifying domains reached 70% or 
more consensus agreement (table 2), suggesting they 
should be included in the assessment of exercise adher-
ence. Two were unanimously voted as important by all 
participants: the patient’s perspective of both the amount 
and frequency of exercise completed and the accuracy of 
exercise completion. Stakeholders agreed that seeking 
perspective of calorie expenditure of a given exercise 
should not be included in the future measurement of 
exercise adherence. Thirteen of 30 influencing domains 
reached 70% or more consensus agreement (table 2), 
suggesting they should be included in the assessment 
of exercise adherence. Three were unanimously agreed 
as important: the patient’s perception of their ability 
to complete exercise despite other commitments, their 
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Table 1 Vote 1: result of nominal group technique stakeholder group consensus of six candidate measures’ suitability for the 
assessment of exercise adherence
How suitable are the six candidate 
measures of exercise adherence 
with respect to
Relevance
Yes (%)
Feasibility
Yes (%)
Acceptability
Yes (%)
Appropriateness
Yes (%)
Overall 
suitability
Yes (%)
HRERS in routine practice 7.1 85.7 7.1 7.1 14.3
HRERS in clinical trials 7.1 64.3 7.1 0.0 0.0
PRPS in routine practice 14.3 85.7 0.0 14.3 14.3
PRPS in clinical trials 7.1 50.0 7.1 0.0 0.0
RAQ in clinical trials 14.3 21.4 0.0 0.0 0.0
SIRAS in routine practice 14.3 85.7 7.1 7.1 7.1
SIRAS in clinical trials 7.1 64.3 14.3 0.0 0.0
AESOP in routine practice 0.0 7.1 0.0 0.0 0.0
AESOP in clinical trials 0.0 14.3 7.1 0.0 0.0
CHAMPS in routine practice 0.0 0.0 0.0 0.0 0.0
CHAMPS in clinical trials 0.0 21.4 0.0 0.0 0.0
RAQ in routine practice 7.1 0.0 0.0 0.0 0.0
RAQ in clinical trials 14.3 21.4 0.0 0.0 0.0
AESOP, Adherence to Exercise Scale for Older Patients; CHAMPS, Community Healthy Activities Model Programme for Seniors; HRERS, 
Hopkins Rehabilitation Engagement Rating Scale; PRPS, Pittsburgh Rehabilitation Participation Scale; RAQ, Rehabilitation Adherence 
Questionnaire (modified); SIRAS, Sports Injury Rehabilitation Adherence Scale.
understanding of the benefits of exercise and self- 
motivation of the patient during exercise.
DIsCussIOn
As far as we are aware, this study describes the first 
consensus- based stakeholder evaluation of exercise adher-
ence measurement for patients with musculoskeletal 
conditions. In the current study, multiple stakeholders, 
including patients, health professionals, researchers and 
service managers agreed that the six identified measures 
of exercise adherence were not suitable for use in routine 
practice or clinical trials due to their lack of relevance, 
acceptability and appropriateness. This is consistent with 
the findings of poor conceptual underpinnings in our 
and other earlier systematic reviews,29 31 which concluded 
that the evaluated exercise adherence measures in these 
reviews are of poor quality and are not fit for purpose. 
These reviews investigated exercise adherence measures 
for different purposes or environments and, coupled with 
our work, highlight the overall poor quality of these exer-
cise adherence measures for all contexts and provide crit-
ical insight into the many failings of published measures 
of exercise adherence. However, we are aware that since 
this study was conducted, the Exercise Adherence Rating 
Scale (EARS) has been developed and preliminary testing 
of face and construct validity, internal consistency and 
reliability suggest that it is a promising new measure of 
exercise adherence in patients with MSK disorders.41 42 
There remains a pressing need to prioritise further devel-
opment of good quality measures that capture adherence 
to therapeutic exercise. Stakeholders agree that 25 of the 
46 domains considered could make an important contri-
bution to the measurement of exercise adherence. These 
domains sought to both quantify adherence to exercise 
(eg, the amount, frequency and accuracy of completed 
exercise) and to gain insight into the factors that influ-
ence adherence (eg, the patient’s ability to complete 
exercise despite other commitments). This perspective is 
also supported by the recent research related to the devel-
opment of the EARS.42
Earlier qualitative work has highlighted differences 
in outcomes considered important by patients/carers 
versus health professionals,43 and therefore a strength of 
this study was the inclusion of multiple stakeholders to 
provide different perspectives on adherence measures, 
the constituents of exercise adherence and how they 
should be assessed. The involvement of patients in the 
research process as research partners is increasingly 
viewed as enhancing the development and evaluation 
of relevant and acceptable patient- centred outcome 
assessment.44 The variation in perspectives found in this 
study indicates the requirement for multiple stakeholder 
involvement in the future development of adherence 
measures which are suitable for use in research and clin-
ical practice. An additional strength of the study was that 
measures and measurement domains considered by the 
stakeholder group were derived from a large rigorous 
systematic review30 ensuring that at the time the most 
contemporary material has been presented for evalua-
tion. It is recognised omissions exist as recently published 
work41 42 could not be included, although stakeholder 
proposed domains were added. The number of consensus 
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Table 2 Vote 2: ranked results of nominal group technique stakeholder group consensus of the inclusion of ‘quantifying ’ and 
'influencing' domains in the assessment of exercise adherence
Should the following quantifying domain be included in the future measurement of exercise 
adherence? Yes (%) No (%)
The amount and frequency of completed exercise (patient’s perspective) 100.0 0.0
Accuracy of exercise completion (patient’s perspective)* 100.0 0.0
The extent to which the patient follows a clinician’s instructions (patient’s perspective) 92.9 7.1
Attendance at rehabilitation sessions (clinician’s perspective): 92.9 7.1
The extent to which the exercise works towards an agreed goal (patient’s perspective)* 92.9 7.1
Accuracy of exercise completion (clinician's perspective)* 92.9 7.1
The amount and frequency of completed exercise (clinician’s perspective) 85.7 14.3
The extent to which the patient follows a clinician’s instructions (clinician’s perspective) 85.7 14.3
Attendance at rehabilitation sessions (patient’s perspective) 85.7 14.3
The extent to which the patient actively participates in exercise (patient’s perspective) 85.7 14.3
The extent to which the exercise works towards an agreed goal (clinician's perspective)* 85.7 14.3
The extent to which the patient actively participates in exercise (clinician’s perspective) 71.4 28.6
The signs of physical or mental demands during exercise (patient’s perspective) 57.1 42.9
The signs of physical or mental demands during exercise (clinician’s perspective) 42.9 57.1
Calorie expenditure of a given exercise (patient’s perspective) 14.3 85.7
Calorie expenditure of a given exercise (clinician’s perspective) 0.0 100.0
Should the following influencing domain be included in the future measurement of exercise adherence?
The patient’s ability to complete exercise despite other commitments (patient’s perspective)* 100.0 0.0
The patient’s understanding of the benefits of exercise (patient’s perspective) 100.0 0.0
Patient/clinician agreement of exercise recommendations (patient's perspective) 100.0 0.0
Self- motivation of the patient during exercise (patient’s perspective) 85.7 14.3
The patient’s ability to complete exercise, although it is challenging (patient’s perspective) 85.7 14.3
The patient’s understanding of the benefits of exercise (clinician’s perspective) 85.7 14.3
The patient's attitude toward exercise (patient’s perspective): 85.7 14.3
Patient/clinician agreement of exercise recommendations (clinician's perspective)* 85.7 14.3
The level of patient support received from family and friends (patient’s perspective) 78.6 21.4
The patient’s ability to complete exercise despite other commitments (clinician’s perspective) 78.6 21.4
The patient’s ability to complete exercise although it is challenging (clinician’s perspective) 78.6 21.4
The patient's attitude toward exercise (clinician’s perspective) 71.4 28.6
The relationship between clinician and patient (patient's perspective)* 71.4 28.6
The patient’s pain tolerance during exercise (patient’s perspective) 64.3 35.7
Self- motivation of the patient during exercise (clinician’s perspective) 64.3 35.7
The relationship between clinician and patient (clinician's perspective)* 64.3 35.7
The patient’s pain tolerance during exercise (clinician’s Perspective) 50.0 50.0
The patient’s receptiveness to change in a therapeutic exercise programme (patient’s perspective) 50.0 50.0
The extent to which the patient completes exercise without encouragement (clinician’s perspective) 50.0 50.0
The patient's ability to resume exercise following a forced break (patient’s perspective) 50.0 50.0
The patient’s receptiveness to change in a therapeutic exercise programme (clinician’s p) 42.9 57.1
The patient's enjoyment of exercise (patient’s perspective) 42.9 57.1
The patient's ability to resume exercise following a forced break (clinician’s perspective) 42.9 57.1
The level of patient support received from family and friends (clinician’s perspective) 35.7 64.3
The extent to which the patient completes exercise without encouragement (patient’s perspective) 35.7 64.3
The amount of prompting required to complete an exercise correctly (clinician’s perspective) 21.4 78.6
Continued
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Should the following influencing domain be included in the future measurement of exercise adherence?
The suitability of the exercise environment for the patient’s needs (patient’s perspective) 21.4 78.6
The patient’s enjoyment of exercise (clinician’s perspective) 21.4 78.6
The amount of prompting required to complete an exercise correctly (patient’s perspective) 14.3 85.7
The suitability of the exercise environment for the patient’s needs (clinician’s perspective) 14.3 85.7
Domains achieving the consensus threshold level of 70%+ are denoted in bold.
*Group developed domains.
Table 2 Continued
group participants is a possible limitation, although 
agreement about what constitutes an optimum group size 
could not be found. Guidance on the appropriate mix of 
participants in a consensus workshop also does not exist; 
therefore, in line with advice received from our patient 
and public involvement group, the target sample was 
weighted to reflect the experiences and perspectives of 
patients.45 The group was UK based, which may limit the 
generalisability of our findings to other settings. Under-
standing an international stakeholder’s perspective of 
the components of exercise adherence is imperative 
if future measures are to be developed with global and 
cultural validity. It is also possible that the patient stake-
holders who participated in this study might be consid-
ered adherent and therefore may not fully represent the 
views of non- adherent populations. Seeking the views of a 
non- adherent population would be ideal, although diffi-
cult to capture.
Further analysis of isolated voting patterns show simple 
quantification of exercise completion was viewed as 
important by all stakeholders but as insufficient by both 
physiotherapists and patient stakeholders. However, this 
view was not shared by researchers who indicted that 
simple quantification of adherence was the priority. The 
modified NGT was robust with workshop discussions not 
only reflecting domain development and voting patterns 
but also adding understanding throughout. Patient 
representatives alone would have reached consensus on 
15 influencing domains as opposed to 10 by healthcare 
professionals indicating their belief of importance in 
understanding factors affecting adherence. This variance 
in perspectives points towards potential differences in 
the way that adherence instruments may be used within 
research and clinical practice. In clinical practice, under-
standing patient non- adherence and exploration of 
factors related to that non- adherence may inform a phys-
iotherapist’s reasoning and future management strategy 
to optimise therapeutic outcomes.
This study has identified that these six measures of 
adherence with therapeutic exercise lack validity, reli-
ability and acceptability to clinicians, managers, patients 
and researchers and have to date been poorly concep-
tualised. There is a need for valid and reliable exercise 
adherence measures which are suitable and acceptable 
for use with musculoskeletal populations in both clin-
ical and research settings. These findings do not provide 
definitive domains for a new measure of exercise adher-
ence, but they can form a foundation that may be evalu-
ated alongside recent work by multiple stakeholders in 
international and varied socioeconomic settings in the 
future. It is evident that stakeholders were in unanimous 
agreement that to be acceptable, any measure should look 
at psychological and social determinants of adherence, 
not simple quantification of adherence. These contextual 
factors included cognitive factors (eg, the patient’s under-
standing of the benefits of exercise and patient/clinician 
agreement of exercise recommendation), psychological 
factors (eg, self- motivation of the patient during exercise) 
and social factors (eg, the patient’s ability to complete 
exercise despite other commitments and the level of 
patient support received from friends and family). This 
raises the prospect of an adherence profile which might 
consist of scales that (1) quantify adherence with thera-
peutic exercise and (2) measure important determinants 
of exercise adherence.
There is a significant shortfall between the way exercise 
adherence is currently assessed when compared against the 
emerging biopsychosocial conceptual framework described 
here. This study has confirmed the complex nature of 
exercise adherence; it is a construct with both observable 
and non- observable components. Consensus suggests that 
it can, and should, be understood from the perspective 
of several key stakeholders; the clinician, the researcher 
and the patient. However, adherence to exercise has not 
been clearly defined from the perspective of any of these 
stakeholders, and hence the conceptual underpinning 
which provides an essential framework for measurement 
is not available. The first step in the development of any 
future measure of adherence must be to establish or adapt 
recognised conceptual models and theoretical frameworks42 
to the related domains within the concept of exercise adher-
ence for MSDs.46 Development of the conceptual model 
and framework will be required to address a wide range of 
issues, including the multifaceted nature of adherence, the 
focus of the measure (eg, evaluation, categorisation and 
prognostication) and issues of cross- cultural validity if the 
measure were to be applied across international settings. A 
patient- centred collaborative approach towards developing 
a measure of exercise adherence is essential to enable the 
true burden of exercise adherence to be described and the 
relative success of healthcare which seeks to prescribe exer-
cise to be comprehensively understood.47
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COnClusIOn
At the time of undertaking, six measures of exercise 
adherence were available for incorporation within this 
study. Participants in the first UK- based patient- centred 
and NGT workshop unanimously rejected all six measures 
due to a perceived lack of suitability for routine practice 
or clinical trials. Exercise adherence must be clearly 
conceptualised to facilitate appropriate and robust assess-
ment. Stakeholders in this study agreed on 25 domains of 
exercise adherence as a possible foundation for further 
research to develop a measure of adherence with ther-
apeutic exercise. These domains indicate the possible 
requirement of an adherence profile which (1) quantifies 
adherence with therapeutic exercise and (2) measures 
important determinants of exercise adherence. Multiple 
stakeholders will need to take a patient- centred collabora-
tive approach to develop any measure of exercise adher-
ence that is of high quality, relevant and appropriate for 
universal use in routine clinical practice and/or clinical 
trials.
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